+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Human Enhancement Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 139 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5911853

Quick Summary:

In an era marked by technological advances and scientific breakthroughs, the human enhancement market has become a critical sector for those aiming to leverage human potential beyond natural limitations. As executives chart their course through the complexities of emerging technology, an in-depth understanding of this evolving market is key to not only staying ahead of the curve but also to capitalizing on the myriad of opportunities it presents.

This comprehensive market research report provides an essential analysis of the human enhancement industry dynamics, detailing how advancements in areas such as gene editing, smart devices, and exoskeletons are revolutionizing healthcare, defense, and information technology sectors. It maps pivotal trends and forecasts crucial developments, offering a clear view of the integrated landscape where technologies improve and extend human capabilities. By dissecting the market segmentation and providing a competitive analysis, this report is the definitive source to help shape strategic decision-making and foster innovative approaches within your organization.

The global human enhancement market size reached US$ 97.9 Billion in 2022. Looking forward, the market is expected to reach US$ 215.9 Billion by 2028, exhibiting a growth rate (CAGR) of 14.09% during 2022-2028.

Human enhancement refers to a natural, artificial, and technological alteration of the body to enhance cognitive and physical capabilities and functions of individuals. It is undertaken using drugs, hormones, implants, genetic engineering to dietary supplements and cosmetic surgeries for self-improvement. Nowadays, advances in human enhancement technologies provide resistance against diseases like malaria, tuberculosis, and Lyme. They also allow up-to-date diagnostic and advancements in genome editing technologies, such as clustered regularly interspaced short palindromic repeats (CRISPR) for a functional cure of human immunodeficiency virus (HIV) infection.

Human Enhancement Market Trends

The growing prevalence of acute and chronic diseases, in confluence with the increasing access to healthcare services, represents one of the key factors positively influencing the demand for human enhancement technologies around the world. These technologies mainly include nanotechnology, information technology (IT), and cognitive science, which assist in upgrading biomedical interventions as well as diagnose and treat various diseases. They also comprise active control systems that help create limb prosthetics with characteristics that exceed human performance. Moreover, emerging technologies like genetic engineering, neuronal implants, brain-computer interfaces, and three-dimensional (3D) bioprinting are contributing to the market growth. Apart from this, due to rising geopolitical tension between countries, security agencies of several countries are investing in research programs to improve battlefield performance. For instance, the ethics committee in the French Army approved the research of human enhancement technologies for developing enhanced soldiers. This research also involves the utilization of advanced systems, ranging from drugs to exoskeletons, to enhance military personnel in targeting decisions. These factors are anticipated to drive the adoption of human enhancement technologies and influence the market positively in the coming years.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global human enhancement market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, device type and end user.

Breakup by Product:

  • Exoskeleton
  • Smart Devices
  • Medical Devices
  • Implants

Breakup by Device Type:

  • Body Worn
  • Non-Body Worn

Breakup by End User:

  • Healthcare
  • Defense
  • Information Technology

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being BrainGate, B-Temia Inc, Ekso Bionics, Google LLC, Magic Leap Inc, Raytheon Technologies Corporation, ReWalk Robotics Ltd, Samsung Electronics Co. Ltd., Second Sight Medical Products Inc. and Vuzix Corporation.

Key Questions Answered in This Report

1. What was the size of the global human enhancement market in 2022?
2. What is the expected growth rate of the global human enhancement market during 2023-2028?
3. What has been the impact of COVID-19 on the global human enhancement market?
4. What are the key factors driving the global human enhancement market?
5. What is the breakup of the global human enhancement market based on the product?
6. What is the breakup of the global human enhancement market based on the device type?
7. What is the breakup of the global human enhancement market based on the end user?
8. What are the key regions in the global human enhancement market?
9. Who are the key players/companies in the global human enhancement market?
Frequently Asked Questions about the Global Human Enhancement Market

What is the estimated value of the Global Human Enhancement Market?

The Global Human Enhancement Market was estimated to be valued at $97.9 Billion in 2022.

What is the growth rate of the Global Human Enhancement Market?

The growth rate of the Global Human Enhancement Market is 14.1%, with an estimated value of $215.9 Billion by 2028.

What is the forecasted size of the Global Human Enhancement Market?

The Global Human Enhancement Market is estimated to be worth $215.9 Billion by 2028.

Who are the key companies in the Global Human Enhancement Market?

Key companies in the Global Human Enhancement Market include Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, DemeTECH Corporation, Integra LifeSciences, Johnson & Johnson, Medtronic plc, Mellon Medical B.V. and Smith & Nephew plc.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Human Enhancement Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Exoskeleton
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Smart Devices
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Medical Devices
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Implants
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Device Type
7.1 Body Worn
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Non-Body Worn
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End User
8.1 Healthcare
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Defense
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Information Technology
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 BrainGate
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 B-Temia Inc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Ekso Bionics
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Google LLC
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Magic Leap Inc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Raytheon Technologies Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 ReWalk Robotics Ltd
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Samsung Electronics Co. Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Second Sight Medical Products Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Vuzix Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials

Companies Mentioned

  • BrainGate
  • B-Temia Inc
  • Ekso Bionics
  • Google LLC
  • Magic Leap Inc
  • Raytheon Technologies Corporation
  • ReWalk Robotics Ltd
  • Samsung Electronics Co. Ltd.
  • Second Sight Medical Products Inc.
  • Vuzix Corporation

Methodology

Loading
LOADING...